asco lung cancer roundtable - new combinations chemo immunotherapy for extensive stage sclc
Published 3 years ago • 125 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
8:13
checkmate 816: combining chemo and opdivo - asco lung review 2022
-
8:43
asco lung cancer roundtable - gronberg study - chest radiation with chemo for limited stage sclc
-
4:45
the skyscraper trial: treatments for extensive stage small cell lung cancer - asco lung review 2022
-
9:21
asco lung cancer roundtable - nsclc - new potential treatments for met and ret positive nsclc
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
12:55
patients with high pd-l1: immunotherapy alone or combine with chemo? - asco lung review 2022
-
6:32
asco 2019 lung cancer round table - new cancer research: long term outcomes of pembrolizumab
-
6:52
combination chemotherapy and immunotherapy for patients with high pd-l1 nsclc - 2022 program: lcvl
-
9:40
asco 2018 - checkmate 227 - combinations of nivolumab and ipilimumab, or nivolumab and and chemo
-
11:48
asco lung cancer roundtable - nsclc trial updates: checkmate 9la opdivo and yervoy with chemo vs
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
5:24
asco 2019 lung cancer roundtable - lurbinectedin - how promising is this for relapsed sclc
-
11:36
immunotherapy for lung cancer: currently enrolling clinical trials of combination therapies
-
11:42
asco lung cancer roundtable - nsclc trial updates: checkmate 227 opdivo yervoy combination today
-
6:57
lung cancer video library - chemo immuno therapy combinations in advanced nsclc
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
5:39
lung cancer video library - chemo immuno therapy combinations in advanced squamous nsclc